Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 16,639 | 21,344 | 18,814 | 23,164 | 18,350 |
| Cost of Goods | 6,768 | 6,955 | 7,090 | 9,778 | 9,971 |
| Gross Profit | 9,871 | 14,389 | 11,724 | 13,386 | 8,379 |
| Operating Expenses | 24,051 | 21,056 | 20,163 | 25,248 | 30,935 |
| Operating Income | -13,412 | -5,712 | -8,349 | -11,084 | -21,585 |
| Interest Expense | 2,492 | 2,586 | 2,625 | 2,606 | 2,612 |
| Other Income | 300 | 91 | 485 | 588 | 776 |
| Pre-tax Income | -15,604 | -8,207 | -10,489 | -13,102 | -23,421 |
| Income Tax | 48 | -8 | 44 | 47 | 63 |
| Net Income Continuous | -15,652 | -8,199 | -10,533 | -13,149 | -23,484 |
| Net Income | $-15,652 | $-8,199 | $-10,533 | $-13,149 | $-23,484 |
| EPS Basic Total Ops | -0.32 | -0.16 | -0.21 | -0.27 | -0.48 |
| EPS Basic Continuous Ops | -0.32 | -0.16 | -0.21 | -0.27 | -0.48 |
| EPS Diluted Total Ops | -0.32 | -0.16 | -0.21 | -0.27 | -0.48 |
| EPS Diluted Continuous Ops | -0.32 | -0.16 | -0.21 | -0.27 | -0.48 |
| EPS Diluted Before Non-Recurring Items | -0.32 | -0.17 | -0.18 | -0.27 | -0.35 |
| EBITDA(a) | $-11,614 | $-3,860 | $-6,524 | $-9,158 | $-19,534 |